Moderna may take months to ship Omicron-specific vaccine, CEO says | ABS-CBN
ADVERTISEMENT

Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
Moderna may take months to ship Omicron-specific vaccine, CEO says
Moderna may take months to ship Omicron-specific vaccine, CEO says
Reuters
Published Nov 30, 2021 12:08 AM PHT

Moderna Inc could take months to begin shipping a COVID-19 vaccine that works specifically against the Omicron variant, its chief executive officer, Stéphane Bancel, told CNBC on Monday.
Moderna Inc could take months to begin shipping a COVID-19 vaccine that works specifically against the Omicron variant, its chief executive officer, Stéphane Bancel, told CNBC on Monday.
The Omicron variant carries a very high global risk of surges, the WHO warned on Monday, as more countries reported cases.
The Omicron variant carries a very high global risk of surges, the WHO warned on Monday, as more countries reported cases.
Bancel told CNBC in an interview that the efficacy of COVID-19 vaccines against the variant was currently not known, and that there should be more clarity in about two weeks.
Bancel told CNBC in an interview that the efficacy of COVID-19 vaccines against the variant was currently not known, and that there should be more clarity in about two weeks.
Moderna said on Friday it was working to advance a booster candidate tailored to the new variant and has also been testing a higher dose of its existing booster and to study other booster candidates designed to protect against multiple variants.
Moderna said on Friday it was working to advance a booster candidate tailored to the new variant and has also been testing a higher dose of its existing booster and to study other booster candidates designed to protect against multiple variants.
ADVERTISEMENT
Separately, rivals Pfizer and BioNTech, and Johnson & Johnson have also said they have begun testing their vaccines against the new variant.
Separately, rivals Pfizer and BioNTech, and Johnson & Johnson have also said they have begun testing their vaccines against the new variant.
RELATED VIDEO
ADVERTISEMENT
ADVERTISEMENT